BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2610823)

  • 1. Central corticotropin releasing factor reduces natural cytotoxicity. Time course of action.
    Irwin M; Jones L; Britton K; Hauger RL
    Neuropsychopharmacology; 1989 Dec; 2(4):281-4. PubMed ID: 2610823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat.
    Irwin M; Hauger R; Brown M
    Endocrinology; 1992 Sep; 131(3):1047-53. PubMed ID: 1505449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRF activates autonomic nervous system and reduces natural killer cytotoxicity.
    Irwin M; Hauger RL; Brown M; Britton KT
    Am J Physiol; 1988 Nov; 255(5 Pt 2):R744-7. PubMed ID: 2847561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central corticotropin-releasing factor suppresses natural killer cytotoxicity.
    Irwin MR; Vale W; Britton KT
    Brain Behav Immun; 1987 Mar; 1(1):81-7. PubMed ID: 3502536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity.
    Irwin M; Hauger RL; Jones L; Provencio M; Britton KT
    J Pharmacol Exp Ther; 1990 Oct; 255(1):101-7. PubMed ID: 2120421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats.
    Arase K; York DA; Shimizu H; Shargill N; Bray GA
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E255-9. PubMed ID: 3262311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity.
    Irwin M; Vale W; Rivier C
    Endocrinology; 1990 Jun; 126(6):2837-44. PubMed ID: 2161737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats.
    Arase K; Shargill NS; Bray GA
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R751-6. PubMed ID: 2784291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization.
    Hauger RL; Irwin MR; Lorang M; Aguilera G; Brown MR
    Brain Res; 1993 Jul; 616(1-2):283-92. PubMed ID: 8395304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intracerebroventricular CRF infusion attenuates ACTH-corticosterone release.
    Cunningham JJ; Meara PA; Lee RY; Bode HH
    Am J Physiol; 1988 Aug; 255(2 Pt 1):E213-7. PubMed ID: 2841865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticotropin-releasing factor on energy balance in rats are sex dependent.
    Rivest S; Deshaies Y; Richard D
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1417-22. PubMed ID: 2604001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
    Swerdlow NR; Britton KT; Koob GF
    Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.
    Krahn DD; Gosnell BA; Levine AS; Morley JE
    Brain Res; 1988 Mar; 443(1-2):63-9. PubMed ID: 2834018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
    de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
    Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala.
    Singh VB; Hao-Phan T; Corley KC; Boadle-Biber MC
    Neurochem Int; 1992 Jan; 20(1):81-92. PubMed ID: 1304322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
    Brown MR; Carver-Moore K; Gray TS; Rivier C
    Endocrinology; 1989 Nov; 125(5):2558-62. PubMed ID: 2551657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central interferon-alpha inhibits natural killer cytotoxicity through sympathetic innervation.
    Take S; Mori T; Katafuchi T; Hori T
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R453-9. PubMed ID: 8368401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracerebroventricular administration of ovine corticotropin-releasing factor (CRF 1-41) on passive avoidance behaviour: lack of influence on monoamine contents of limbic brain areas.
    Fekete M; Balázs M; Telegdy G; Schally AV
    Neuropeptides; 1985 Jul; 6(4):283-292. PubMed ID: 3876519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF.
    Million M; Taché Y; Anton P
    Am J Physiol; 1999 Apr; 276(4):G1027-36. PubMed ID: 10198347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.